They received a significant second round funding of €2.3M from LUMO Labs, ROM InWest, Pathena Venture Capital (Portugal), and Leistone (Renza Family).

They will use it to enhance its innovative AI system designed to predict and prevent surgical complications. The investment is a follow-up investment after a first round investment from the TTT-AI pre-seed fund managed by LUMO Labs.

Healthplus.ai's advanced AI system, PERISCOPE®, is designed to minimize surgical complications, speed up recovery times, and reduce hospital expenses. By analyzing patient data, the system can predict the risk of post-surgery infections and suggest measures to prevent them, helping surgical teams to proactively address potential issues.

“With this late-seed investment, we’re strengthening our ability to bring clinically validated, regulatory-approved AI into everyday hospital practice. Our focus remains on close collaboration with surgeons, clinicians, and hospital IT teams to ensure that predictive insights truly improve patient outcomes,” said Dr Bart Geerts, CEO and founder of Healthplus.ai.

The new funds will be used to expand Healthplus.ai's presence across Europe and the U.S., secure regulatory approvals, enhance compatibility with major electronic health record (EHR) systems, and refine its AI models to cover all stages of surgery and various types of complications. This means that more hospitals will be able to use technology to improve patient care and reduce costs.

Want to know more about Healtplus.ai? Visit their website here.

About LUMO Labs

LUMO Fund is a MEUR 100 multi-stage (Pre-Seed to Series A) impact-driven venture capital fund, with a proprietary startup coaching program for purpose-driven founders, who seek to bring technological innovations to the market to help solve social and environmental challenges. 

LUMO Labs VC invests in scalable startups using disruptive technologies such as Artificial Intelligence & Data, Blockchain, Internet of Things, Digital Security, and Extended Realities (AR/VR), contributing to one of the following SDGs: Health & Wellbeing, Quality Education, Sustainable Cities & Communities, and Climate Action.

LUMO is a pan-European fund with a focus on Benelux and Germany, Nordics, Baltics and the Iberian Peninsula. LUMO Fund is the successor fund of LUMO Fund II managed by LUMO Labs, founded in 2016 by former tech entrepreneurs Andy Lürling and Sven Bakkes.

LUMO Labs media contact:

Andy Lurling, Founding Partner; andy@lumolabs.io